Alzheimer's & Cognition
Conference Coverage
Global burden of brain disorders surpasses cardiovascular disease and cancer
“The burden of brain conditions will increase as populations continue to grow and age.”
From the Journals
Men and women react differently to acute stress
In men, stress rapidly improved the ability to downregulate emotional arousal via distraction that was fully mediated by cortisol.
Latest News
New consensus on biomarkers for diagnosis of neurocognitive disorders
Reducing the options available to clinicians when making a differential diagnosis into the current algorithm is a pragmatic approach.
Feature
Long COVID ‘brain fog’ confounds doctors, but new research offers hope
Brain fog is among the most common symptoms of long COVID, and also one of the most poorly understood.
News
Lean muscle mass protective against Alzheimer’s?
The finding suggesting that lean mass is associated with better cognitive function is “important, as cognitive impairment can become stable rather...
News
Regular napping linked to greater brain volume
“Our results suggest that napping may improve brain health.”
From the Journals
SSRI improves cognition, major depression in early dementia
Improvements in depressive symptoms were irrespective of dementia type.
News
Altered gut bacteria a biomarker of preclinical Alzheimer’s?
It’s not known whether the gut is influencing the brain, or the brain is influencing the gut, “but this association is valuable to know in either...
From the Journals
Patients with post-COVID cognitive symptoms may have gliosis
“This is an important initial step to better understand the neuropsychiatric consequences of COVID even in only a mild and moderate viral illness...
Commentary
Daily multivitamins boost memory in older adults: A randomized trial
Multivitamin supplementation holds promise as a safe, accessible, and affordable approach to protecting cognitive health in older adults.
FDA/CDC
FDA panel unanimously endorses lecanemab for Alzheimer’s
An intravenous infusion targeting amyloid-beta, lecanemab received accelerated FDA approved earlier in 2023 for the treatment of early Alzheimer’s...